Female sexual dysfunction in patients with sub-stance-related disorders

Detalhes bibliográficos
Autor(a) principal: Diehl, Alessandra
Data de Publicação: 2013
Outros Autores: Silva, Rosiane Lopes da, Laranjeira, Ronaldo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/53160
Resumo: OBJECTIVE: To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit. METHODS: This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence Data questionnaire, Fagerstrom Test for Nicotine Dependence, and Arizona Sexual Experience Scale were also administered. RESULTS: The sample consisted of 105 women who had a mean age of 34.8 years (SD = 12.1, range = 18-65) and were predominantly heterosexual (74.3%), single (47.6%), Caucasian (50.5%), catholic (36.2%), and educated only to the level of primary education (40%), with a monthly family income of up to one minimum salary (37.5%). In 42.9% of the patients, crack was the drug of choice; 47.6% of the sample qualified for the Drug Abuse Screening Test (substantial problems related to drugs), 43.8% exhibited Short Alcohol Dependence Data (moderate or severe dependency), 47.6% exhibited Fagerstrom Test for Nicotine Dependence (high or very high nicotine dependence). The prevalence of sexual dysfunction symptoms was 34.2% (95% CI = [25.3, 44.1]), and a high level of nicotine dependence and low income increased the chances of having sexual dysfunction by 2.72-fold and 2.54 fold, respectively. An association was also observed between female sexual dysfunction symptoms and schooling and levels of drug dependence. CONCLUSIONS: Female sexual dysfunction symptoms were common among this sample and primarily associated with high levels of nicotine use.
id USP-19_79a795bc8d62e4f702ba9fe9c9433816
oai_identifier_str oai:revistas.usp.br:article/53160
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Female sexual dysfunction in patients with sub-stance-related disorders Sexual DysfunctionSubstance-Related DisordersWomenCrack^i1^sCocaTobacco Use Disorder OBJECTIVE: To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit. METHODS: This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence Data questionnaire, Fagerstrom Test for Nicotine Dependence, and Arizona Sexual Experience Scale were also administered. RESULTS: The sample consisted of 105 women who had a mean age of 34.8 years (SD = 12.1, range = 18-65) and were predominantly heterosexual (74.3%), single (47.6%), Caucasian (50.5%), catholic (36.2%), and educated only to the level of primary education (40%), with a monthly family income of up to one minimum salary (37.5%). In 42.9% of the patients, crack was the drug of choice; 47.6% of the sample qualified for the Drug Abuse Screening Test (substantial problems related to drugs), 43.8% exhibited Short Alcohol Dependence Data (moderate or severe dependency), 47.6% exhibited Fagerstrom Test for Nicotine Dependence (high or very high nicotine dependence). The prevalence of sexual dysfunction symptoms was 34.2% (95% CI = [25.3, 44.1]), and a high level of nicotine dependence and low income increased the chances of having sexual dysfunction by 2.72-fold and 2.54 fold, respectively. An association was also observed between female sexual dysfunction symptoms and schooling and levels of drug dependence. CONCLUSIONS: Female sexual dysfunction symptoms were common among this sample and primarily associated with high levels of nicotine use. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2013-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/5316010.6061/CLINICS/2013(02)OA14Clinics; Vol. 68 No. 2 (2013); 205-212 Clinics; v. 68 n. 2 (2013); 205-212 Clinics; Vol. 68 Núm. 2 (2013); 205-212 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/53160/57221Diehl, AlessandraSilva, Rosiane Lopes daLaranjeira, Ronaldoinfo:eu-repo/semantics/openAccess2013-04-08T20:40:36Zoai:revistas.usp.br:article/53160Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2013-04-08T20:40:36Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Female sexual dysfunction in patients with sub-stance-related disorders
title Female sexual dysfunction in patients with sub-stance-related disorders
spellingShingle Female sexual dysfunction in patients with sub-stance-related disorders
Diehl, Alessandra
Sexual Dysfunction
Substance-Related Disorders
Women
Crack^i1^sCoca
Tobacco Use Disorder
title_short Female sexual dysfunction in patients with sub-stance-related disorders
title_full Female sexual dysfunction in patients with sub-stance-related disorders
title_fullStr Female sexual dysfunction in patients with sub-stance-related disorders
title_full_unstemmed Female sexual dysfunction in patients with sub-stance-related disorders
title_sort Female sexual dysfunction in patients with sub-stance-related disorders
author Diehl, Alessandra
author_facet Diehl, Alessandra
Silva, Rosiane Lopes da
Laranjeira, Ronaldo
author_role author
author2 Silva, Rosiane Lopes da
Laranjeira, Ronaldo
author2_role author
author
dc.contributor.author.fl_str_mv Diehl, Alessandra
Silva, Rosiane Lopes da
Laranjeira, Ronaldo
dc.subject.por.fl_str_mv Sexual Dysfunction
Substance-Related Disorders
Women
Crack^i1^sCoca
Tobacco Use Disorder
topic Sexual Dysfunction
Substance-Related Disorders
Women
Crack^i1^sCoca
Tobacco Use Disorder
description OBJECTIVE: To estimate the prevalence of female sexual dysfunction symptoms and the associated risk factors in a sample of patients with substance-related disorders admitted to a specialized in-patient care unit. METHODS: This study used a cross-section design, with eight months of data collection, conducted with substance-dependent women using structured questionnaires to collect socio-demographic data and identify their drug of choice. The Drug Abuse Screening Test, Short Alcohol Dependence Data questionnaire, Fagerstrom Test for Nicotine Dependence, and Arizona Sexual Experience Scale were also administered. RESULTS: The sample consisted of 105 women who had a mean age of 34.8 years (SD = 12.1, range = 18-65) and were predominantly heterosexual (74.3%), single (47.6%), Caucasian (50.5%), catholic (36.2%), and educated only to the level of primary education (40%), with a monthly family income of up to one minimum salary (37.5%). In 42.9% of the patients, crack was the drug of choice; 47.6% of the sample qualified for the Drug Abuse Screening Test (substantial problems related to drugs), 43.8% exhibited Short Alcohol Dependence Data (moderate or severe dependency), 47.6% exhibited Fagerstrom Test for Nicotine Dependence (high or very high nicotine dependence). The prevalence of sexual dysfunction symptoms was 34.2% (95% CI = [25.3, 44.1]), and a high level of nicotine dependence and low income increased the chances of having sexual dysfunction by 2.72-fold and 2.54 fold, respectively. An association was also observed between female sexual dysfunction symptoms and schooling and levels of drug dependence. CONCLUSIONS: Female sexual dysfunction symptoms were common among this sample and primarily associated with high levels of nicotine use.
publishDate 2013
dc.date.none.fl_str_mv 2013-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/53160
10.6061/CLINICS/2013(02)OA14
url https://www.revistas.usp.br/clinics/article/view/53160
identifier_str_mv 10.6061/CLINICS/2013(02)OA14
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/53160/57221
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 68 No. 2 (2013); 205-212
Clinics; v. 68 n. 2 (2013); 205-212
Clinics; Vol. 68 Núm. 2 (2013); 205-212
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222759733690368